Matches in SemOpenAlex for { <https://semopenalex.org/work/W2400972246> ?p ?o ?g. }
Showing items 1 to 90 of
90
with 100 items per page.
- W2400972246 abstract "A fundamental limitation in the development of new therapies to prevent metastatic cancer is a lack of in vitro systems that can accurately recapitulate the steps of cancer cell metastasis. Currently, most assays for examining the steps of metastasis fail to incorporate the biophysical forces experienced by tumor cells due to blood flow, or are low throughput and thereby not amenable to drug screens or high throughput experimentation. We have developed a novel high throughput mesofluidic platform for assaying cell adhesion under flow in a 96-well format. This device functions like a cone and plate viscometer in each well by inducing shear stress on cells cultured in a standard 96-well plate. We validated the fluid flow and alignment of the device and studied the adhesion of cultured leukocytic monocytes (THP-1 cells) and multiple cancer cell lines (MDA-MB-231 and MCF-7 breast cancer cell lines) to purified extracellular matrix molecules (ECM), endothelial cells and immobilized platelets. Assays were carried out under flow (0.5 dynes/cm 2 shear stress) and static conditions. Our studies show that adhesion assays performed under flow yield markedly different results from static adhesion assays. Treatment of breast cancer cells with a small library of integrin inhibitors demonstrated that these compounds had minimal effect on cancer cell adhesion to endothelial cells or immobilized platelets under static conditions, whereas under shear conditions many of these compounds significantly reduced adhesion of cancer cells. As well, this experiment elucidated integrins important for breast cancer adhesion to endothelial cells and platelets. A static adhesion assay of breast cancer cells to various types of ECM showed greater adhesion of the less aggressive MCF-7 cell line in comparison to the more aggressive MDA-MB-231 cell line. In contrast, flow incorporating assays showed increased adhesion of the more aggressive MDA-MB-231 breast cancer cell line. Specifically, the shear assay saw a significant increase in adhesion for multiple ECM as well as an increase in the strength of adhesion to laminin. Finally, we performed a high throughput screening experiment using a kinase inhibitor library of 80 compounds and found that the shear based assay yielded notably different results from a similar screen under static conditions for breast cancer cell adhesion to endothelial cells, immune cell adhesion to endothelial cells and breast cancer cell adhesion to platelets. This shear experiment yielded seven hits, many of which match targets of drugs in clinical trials. In conclusion, our studies show that adhesion assays performed under flow yield markedly different results from static adhesion assays, and are better at identifying both aggressive cancer cells lines and known pathways for circulating cancer and immune cell adhesion. Thus, this high-throughput screening platform may enable the development of novel compounds to inhibit cancer metastasis and facilitate the study of the systems level behavior of cancer-endothelium adhesion. Citation Format: Spencer A, Spruell C, Nandi S, Le V, Crexiell M, Dunn AK, Baker AB. Mesofluidic platform for high throughput screening of inhibitors of metastasis. [abstract]. In: Proceedings of the Thirty-Eighth Annual CTRC-AACR San Antonio Breast Cancer Symposium: 2015 Dec 8-12; San Antonio, TX. Philadelphia (PA): AACR; Cancer Res 2016;76(4 Suppl):Abstract nr P2-05-18." @default.
- W2400972246 created "2016-06-24" @default.
- W2400972246 creator A5008974373 @default.
- W2400972246 creator A5021497612 @default.
- W2400972246 creator A5028908499 @default.
- W2400972246 creator A5035710606 @default.
- W2400972246 creator A5058147919 @default.
- W2400972246 creator A5071715176 @default.
- W2400972246 creator A5075842676 @default.
- W2400972246 date "2016-02-15" @default.
- W2400972246 modified "2023-09-27" @default.
- W2400972246 title "Abstract P2-05-18: Mesofluidic platform for high throughput screening of inhibitors of metastasis" @default.
- W2400972246 doi "https://doi.org/10.1158/1538-7445.sabcs15-p2-05-18" @default.
- W2400972246 hasPublicationYear "2016" @default.
- W2400972246 type Work @default.
- W2400972246 sameAs 2400972246 @default.
- W2400972246 citedByCount "0" @default.
- W2400972246 crossrefType "proceedings-article" @default.
- W2400972246 hasAuthorship W2400972246A5008974373 @default.
- W2400972246 hasAuthorship W2400972246A5021497612 @default.
- W2400972246 hasAuthorship W2400972246A5028908499 @default.
- W2400972246 hasAuthorship W2400972246A5035710606 @default.
- W2400972246 hasAuthorship W2400972246A5058147919 @default.
- W2400972246 hasAuthorship W2400972246A5071715176 @default.
- W2400972246 hasAuthorship W2400972246A5075842676 @default.
- W2400972246 hasConcept C121608353 @default.
- W2400972246 hasConcept C126322002 @default.
- W2400972246 hasConcept C1491633281 @default.
- W2400972246 hasConcept C178790620 @default.
- W2400972246 hasConcept C185592680 @default.
- W2400972246 hasConcept C189165786 @default.
- W2400972246 hasConcept C195687474 @default.
- W2400972246 hasConcept C203014093 @default.
- W2400972246 hasConcept C2779013556 @default.
- W2400972246 hasConcept C502942594 @default.
- W2400972246 hasConcept C530470458 @default.
- W2400972246 hasConcept C553184892 @default.
- W2400972246 hasConcept C55493867 @default.
- W2400972246 hasConcept C71924100 @default.
- W2400972246 hasConcept C84416704 @default.
- W2400972246 hasConcept C85789140 @default.
- W2400972246 hasConcept C86803240 @default.
- W2400972246 hasConcept C95444343 @default.
- W2400972246 hasConcept C96232424 @default.
- W2400972246 hasConceptScore W2400972246C121608353 @default.
- W2400972246 hasConceptScore W2400972246C126322002 @default.
- W2400972246 hasConceptScore W2400972246C1491633281 @default.
- W2400972246 hasConceptScore W2400972246C178790620 @default.
- W2400972246 hasConceptScore W2400972246C185592680 @default.
- W2400972246 hasConceptScore W2400972246C189165786 @default.
- W2400972246 hasConceptScore W2400972246C195687474 @default.
- W2400972246 hasConceptScore W2400972246C203014093 @default.
- W2400972246 hasConceptScore W2400972246C2779013556 @default.
- W2400972246 hasConceptScore W2400972246C502942594 @default.
- W2400972246 hasConceptScore W2400972246C530470458 @default.
- W2400972246 hasConceptScore W2400972246C553184892 @default.
- W2400972246 hasConceptScore W2400972246C55493867 @default.
- W2400972246 hasConceptScore W2400972246C71924100 @default.
- W2400972246 hasConceptScore W2400972246C84416704 @default.
- W2400972246 hasConceptScore W2400972246C85789140 @default.
- W2400972246 hasConceptScore W2400972246C86803240 @default.
- W2400972246 hasConceptScore W2400972246C95444343 @default.
- W2400972246 hasConceptScore W2400972246C96232424 @default.
- W2400972246 hasLocation W24009722461 @default.
- W2400972246 hasOpenAccess W2400972246 @default.
- W2400972246 hasPrimaryLocation W24009722461 @default.
- W2400972246 hasRelatedWork W1996553643 @default.
- W2400972246 hasRelatedWork W2045258297 @default.
- W2400972246 hasRelatedWork W2062469651 @default.
- W2400972246 hasRelatedWork W2072758361 @default.
- W2400972246 hasRelatedWork W2090071359 @default.
- W2400972246 hasRelatedWork W2091357581 @default.
- W2400972246 hasRelatedWork W2182970561 @default.
- W2400972246 hasRelatedWork W2322233411 @default.
- W2400972246 hasRelatedWork W2339206063 @default.
- W2400972246 hasRelatedWork W2536973317 @default.
- W2400972246 hasRelatedWork W2583374514 @default.
- W2400972246 hasRelatedWork W2592239859 @default.
- W2400972246 hasRelatedWork W2770037689 @default.
- W2400972246 hasRelatedWork W2806744753 @default.
- W2400972246 hasRelatedWork W2809695524 @default.
- W2400972246 hasRelatedWork W2885448584 @default.
- W2400972246 hasRelatedWork W2982627267 @default.
- W2400972246 hasRelatedWork W3113130427 @default.
- W2400972246 hasRelatedWork W3113406071 @default.
- W2400972246 hasRelatedWork W3115709013 @default.
- W2400972246 isParatext "false" @default.
- W2400972246 isRetracted "false" @default.
- W2400972246 magId "2400972246" @default.
- W2400972246 workType "article" @default.